NASDAQ Company offers Life Saving Medical Advances; AI & Immunotherapy for Cancer & Immune Related Diseases Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO) AVCO Filtration … Read More
Breakthrough Medicine: Escozine uses peptides obtained from Scorpion Venom to create alternative oncological medicines for Multiple Medical Conditions Including Covid-19 and Cancer: Quanta Inc., (Stock … Read More
Year End Update for this Up & Coming NASDAQ at the forefront of innovations in healthcare Featuring AI & Immunotherapies. Avalon GloboCare Corp. (NASDAQ:AVCO); Is … Read More
Advances for Tourette Syndrome, Alzheimer’s Disease, Pain Management, Autism Spectrum Disorder & Epilepsy from Proprietary Compounds: SciSparc Ltd. (NASDAQ: SPRC) SPRC Issued U.S. Patent For … Read More
NASDAQ Company at the forefront of innovations in healthcare: Avalon GloboCare Corp. (NASDAQ:AVCO) has AI-Enhanced Protein Design Technology for Cellular Therapy Development AVCO’s Chairman Converts $3.0 … Read More
NASDAQ Companies Including: Biofrontera (NASDAQ:BFRI), Avalon GloboCare Corp. (NASDAQ:AVCO), Palantir Technologies (NYSE: PLTR) and Nvidia (NVDA) lead the Charge and Artificial Intelligence (AI) is at the forefront of innovations … Read More
NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO) – Clinical-Stage CellTech Developer Dedicated to Immune Effector Cell … Read More
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals. Leading Drug Developer and Manufacturer of … Read More
Supplier of Non-Invasive Cardiac Monitoring Systems Expanding Via New Partnerships & OTCQB Uplisting Efforts: CB Scientific Stock Symbol: CBSC CB Scientific, Inc. (CBSC) Executes Manufacturing … Read More
TLRY is Making waves along with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: … Read More
NASDAQ Company Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema (NASDAQ: JUPW) Jupiter Wellness Breaking News: … Read More
SPAC Targeting AI Medical Therapeutics and Diagnostics; (NASDAQ: JUPW) Jupiter Wellness Sponsors Jupiter Wellness Acquisition. AI in medicine is projected to grow 18X from 2018 … Read More
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW) Breaking News: JUPITER, … Read More
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS) – Holistic Approach to Patient-First Health and Wellness … Read More
This NASDAQ has Life Saving Advances in Today’s Most Critical Bio-Science Fields of Cancer & Immune Related Disease, Including COVID-19: Avalon GloboCare Corp. (NASDAQ: AVCO) … Read More
Female Oriented Healthcare Advances with Focus on Permanent Birth Control and Infertility, Clinical Trials Underway: Femasys (NASDAQ: FEMY) – Commitment and Company Focus on Transforming … Read More
IPO Launch on the NASDAQ; $31.6 Million Dollar Raise; Clinical Trials Underway on Key Female Oriented Healthcare Advances: Femasys (NASDAQ: FEMY) – Commitment and Company … Read More
25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON) – Clinical Trials … Read More
25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON) – Clinical Trials … Read More
22 Million in Cash for this NASDAQ insures Operating Capital into Mid 2022; FDA Review of ACER 001 Bodes well for Acer Therapeutics Inc. (NASDAQ: … Read More
Strong Cash Position of $43.2 Million Provides Runway into 2nd half of 2023 to Advance the Company’s Programs for Gain Therapeutics, Inc. (NASDAQ: GANX) – Two … Read More
Biotech Requests Pre-IND Meeting with the US FDA: Jupiter Wellness: NASDAQ: JUPW JW-100 Clinical Program Treatment for Mild to Moderate Eczema Following receipt of a … Read More
Big update for NASDAQ Biotech Jupiter Wellness: NASDAQ: JUPW Applies for IND number from the US Food & Drug Administration Following positive results from the … Read More
Capital Efficient: Clinical Stage NASDAQ Company – Novel Targeted Cancer Therapeutics Company: TRACON Pharmaceuticals (NASDAQ: TCON) – Clinical Trials Progressing on Multiple Novel Cancer Treatments. … Read More
July 26, 2021 (Viz Release) – – The benefits from vaccination are ‘back end’ loaded. Businesses and individual customers need to know that the virus … Read More
JUPW announced a head-to-head trial to comparing JW-100 lotion with Pfizer’s (Nasdaq: PFE) Eucrisa crisaborole ointment 2% for the treatment of patients with mild to … Read More
February 23, 2021 – – CB Scientific, Inc. (Stock Symbol: CBSC) is a Rising Entry into the Multi-Billion Dollar Cardiac Monitoring Medical Device and Technology … Read More
February 4, 2021 (Viz Release) – – There is no science behind WHO and government policies regarding Covid19. These policies are baseless. As show by … Read More
SANTA FE, NM (Viz Release) January 19, 2021 – – As the country reels from a relentless pandemic, New Mexico has been particularly hard hit. … Read More
January 14, 2021 (Viz Release) – – Triple Play BioPharma Company: Sunshine Biopharma (Stock Symbol: SBFM) – BioPharma Company with Worldwide Patents on Effective Cancer … Read More